Time to reduce implementation gaps of lipid-lowering therapy - PACE-CME

Time to reduce implementation gaps of lipidlowering therapy

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Introduction: PCSK9i & LDL-c - Guidelines, Practice & Innovation
Introduction: PCSK9i & LDL-c - Guidelines, Practice & Innovation
PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
Introduction: PCSK9i & LDL-c - Guidelines, Practice & Innovation
- Prof. John Kastelein, MD
Five years of PCSK9i - Lessons from practice: Which patients benefit most?
Five years of PCSK9i - Lessons from practice: Which patients benefit most?
PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
Five years of PCSK9i - Lessons from practice: Which patients benefit most?
- Prof. Erik Stroes, MD
One year after the new ESC/EAS dyslipidemia guidelines
One year after the new ESC/EAS dyslipidemia guidelines
PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
One year after the new ESC/EAS dyslipidemia guidelines
- Prof. François Mach, MD